menu
    • menu

    Looking for Acesulfame Potassium pharmaceutical excipients? Find information on Acesulfame Potassium's applications, manufacturers, suppliers, etc. on PharmaCompass.

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: Potassium acesulfame
    Acesulfame potassium, or acesulfame (Sunett, Sweet One) is an artificial sweetener that is 200 times more sweet than sugar but has zero caloric content. The ADI is defined as the estimated amount that a person can safely consume on average every day over a lifetime without risk. It is estimated that the average daily intake is about 20 percent of the ADI.

    USDMF

    read-more
    read-more

    01

    Gangwal Healthcare Private Ltd

    India
    arrow
    CPhI India 2024
    Booth #8.Q10
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 39527

    Submission : 2024-02-08

    Status : Active

    Type : IV

    Gangwal Healthcare CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FINISHED DOSAGE FORMULATIONS

    Upload your portfolio for free, ask us

    FDF DOSSIERS SUPPLIERS

    read-more
    read-more

    01

    DR REDDYS LABS SA
    India
    arrow
    CPhI India 2024
    Booth #RH.E02
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

    Drug : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

    Dosage Form : FILM; BUCCAL, SUBLINGUAL

    Application Number : 205299

    Country : US

    Patented : No

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    DR REDDYS LABS SA
    India
    arrow
    CPhI India 2024
    Booth #RH.E02
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

    Drug : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

    Dosage Form : FILM; BUCCAL, SUBLINGUAL

    Application Number : 205806

    Country : US

    Patented : No

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    TARO
    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    IBUPROFEN

    Drug : IBUPROFEN

    Dosage Form : SUSPENSION; ORAL

    Application Number : 209207

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    TARO
    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    IBUPROFEN

    Drug : IBUPROFEN

    Dosage Form : SUSPENSION; ORAL

    Application Number : 209204

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    TARO
    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    LEVETIRACETAM

    Drug : LEVETIRACETAM

    Dosage Form : SOLUTION; ORAL

    Application Number : 78774

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    ETHYPHARM USA CORP
    France
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEthypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

    BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

    Drug : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

    Dosage Form : TABLET; SUBLINGUAL

    Application Number : 204431

    Country : US

    Patented : No

    Ethypharm

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    STRIDES PHARMA
    India
    arrow
    CPhI India 2024
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

    POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE

    Drug : PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE

    Dosage Form : FOR SOLUTION; ORAL

    Application Number : 204559

    Country : US

    Patented : No

    Strides Pharma Science

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    ALKEM LABS LTD

    LACOSAMIDE

    arrow
    2024 ACI Convention
    Not Confirmed
    ALKEM LABS LTD
    India
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    LACOSAMIDE

    Drug : LACOSAMIDE

    Dosage Form : SOLUTION; ORAL

    Application Number : 214672

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    AMNEAL PHARMS

    LACOSAMIDE

    arrow
    2024 ACI Convention
    Not Confirmed
    AMNEAL PHARMS
    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    LACOSAMIDE

    Drug : LACOSAMIDE

    Dosage Form : SOLUTION; ORAL

    Application Number : 204839

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    GLAXOSMITHKLINE

    CEFUROXIME AXETIL

    arrow
    2024 ACI Convention
    Not Confirmed
    GLAXOSMITHKLINE
    United Kingdom
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CEFUROXIME AXETIL

    Drug : CEFTIN

    Dosage Form : TABLET; ORAL

    Application Number : 50605

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    EXCIPIENTS BY APPLICATIONS

    Click here to find the perfect excipient manufacturers by their capabilities

    Taste Masking

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more

    MARKET PLACE

    Do you need sourcing support? Ask us

    EXCIPIENTS

    read-more
    read-more
    Australia.png
    Various Excipients needed in Australia [ENA20607]
    A company that focuses on manufacturing and development of various skin care & topical pharmaceutical products is looking for suppliers of Various Excipients for commercial purposes. The required quantity is 20 kg for each. The supplier must support this enquiry with CoA. 1. Stevioside Excipient 2. Acesulfame Potassium Excipient
    20 Sep 2024

    Reply

    20 Sep 2024

    Reply text-arrow

    Reply Comment (2)

    20 Sep 2024

    Germany.png
    Various Excipient needed in Germany [ENA19046]
    A CMO that focuses on manufacturing and packaging of soft gum is looking for suppliers of various excipients for development purposes. The supplier must support this enquiry with EU Food Law, USFDA & CoA. 1. Acesulfame Potassium (0.1 kg) Excipient 2. Sodium Alginate (0.25 kg) Excipient 3. Sodium Chloride (0.5 kg) Excipient 4. Sucralose (0.1 kg) Excipient 5. Ammonium Chloride (0.1 kg) Excipient 6. Hydroxypropyl Methylcellulose (1 kg) Excipient 7. Carbopol 934 (1 kg) Excipient
    15 Feb 2024

    Reply

    15 Feb 2024

    Reply text-arrow

    Reply Comment (8)

    15 Feb 2024

    india-flag.png
    Acesulfame Potassium (100 g) Excipient needed in India [ENA17275]
    A company with 75 years of experience in developing, manufacturing & supplying of herbal extracts is looking for suppliers of Acesulfame Potassium (100 g) Excipient for development purposes. The suppliers must support this enquiry with CoA.
    10 Jun 2023

    Reply

    10 Jun 2023

    Reply text-arrow

    Reply Comment (2)

    10 Jun 2023

    Kenya.png
    Acesulfame Potassium (20 FCL) Excipient needed in Kenya [ENA16246]
    A company based in the US that deals in the distribution of pharmaceutical products is looking for suppliers of Acesulfame Potassium (20 FCL) Excipient for commercial purposes. The suppliers must support this enquiry with CoA.
    30 Jan 2023

    Reply

    30 Jan 2023

    Reply text-arrow

    Reply Comment (8)

    30 Jan 2023

    india-flag.png
    Acesulfame Potassium (25 kg) Excipient needed in India [ENA12846]
    A company that deals in various pharmaceutical products like injections, syrups & hygiene products is looking for suppliers of Acesulfame Potassium (25 kg) Excipient for commercial purpose. The suppliers must support this enquiry with CoA.
    28 Feb 2022

    Reply

    28 Feb 2022

    Reply text-arrow

    Reply Comment (4)

    28 Feb 2022

    PharmaCompass
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search